FDA Office of Women's Health

The Food and Drug Administration Office of Women’s Health (OWH) is soliciting feedback from the public to help inform our strategic priorities. The Federal Register public docket will be open for comments for 60 days. Please share with your stakeholders and communities across the U.S. and territories that you serve.

We look forward to receiving input from the public to ensure that critically important women’s health topics are considered in our science, education, and outreach efforts.